March 23, 2020
First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models
Media
March 23, 2020
Fusion Pharmaceuticals Appoints James J. O’Leary, M.D. As Chief Medical Officer
March 23, 2020
Dr. Matthias Friebe joins Camel-IDS as acting Chief Technology Officer
March 23, 2020
Accelerated road to market approval for CERAMENT® G in the US – BONESUPPORT[TM] submits De Novo application
March 23, 2020
Nordic Nanovector Appoints Dr Dominic Smethurst as Interim Chief Medical Officer
March 20, 2020
Oncopeptides provides update regarding COVID-19 impact on the melflufen clinical program
March 20, 2020
Vicore informs on clinical programs in relation to the current outbreak of COVID-19
March 20, 2020
Impact of corona virus (COVID-19) on Targovax’s operations
March 17, 2020
Orexo presents sales potential of the pharmaceutical pipeline and digital therapies during the Capital Markets Day
March 12, 2020
GenSight Biologics Reports Full Year 2019 Financial Results and provides an Outlook on 2020